These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 31572237)

  • 41. Computerised decision support systems in order communication for diagnostic, screening or monitoring test ordering: systematic reviews of the effects and cost-effectiveness of systems.
    Main C; Moxham T; Wyatt JC; Kay J; Anderson R; Stein K
    Health Technol Assess; 2010 Oct; 14(48):1-227. PubMed ID: 21034668
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systematic review and economic evaluation.
    McLeod C; Bagust A; Boland A; Dagenais P; Dickson R; Dundar Y; Hill RA; Jones A; Mujica Mota R; Walley T
    Health Technol Assess; 2007 Aug; 11(28):1-158, iii-iv. PubMed ID: 17651658
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effectiveness and cost-effectiveness of erythropoiesis-stimulating agents (epoetin and darbepoetin) for treating cancer treatment-induced anaemia (including review of technology appraisal no. 142): a systematic review and economic model.
    Crathorne L; Huxley N; Haasova M; Snowsill T; Jones-Hughes T; Hoyle M; Briscoe S; Coelho H; Long L; Medina-Lara A; Mujica-Mota R; Napier M; Hyde C
    Health Technol Assess; 2016 Feb; 20(13):1-588, v-vi. PubMed ID: 26907163
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Systematic Review of Health Economic Evaluation Studies Developed in Brazil from 1980 to 2013.
    Decimoni TC; Leandro R; Rozman LM; Craig D; Iglesias CP; Novaes HMD; de Soárez PC
    Front Public Health; 2018; 6():52. PubMed ID: 29541630
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluating cost-effectiveness in the management of neuroendocrine neoplasms.
    White BE; Mujica-Mota R; Snowsill T; Gamper EM; Srirajaskanthan R; Ramage JK
    Rev Endocr Metab Disord; 2021 Sep; 22(3):647-663. PubMed ID: 33155118
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A systematic review of health economic evaluation in orthotics and prosthetics: Part 2-orthotics.
    Clarke L; Dillon MP; Shiell A
    Prosthet Orthot Int; 2021 Jun; 45(3):221-234. PubMed ID: 33856150
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Systematic Review of Health Economic Evaluations of Diagnostic Tests in Brazil: How accurate are the results?
    Oliveira MRF; Leandro R; Decimoni TC; Rozman LM; Novaes HMD; De Soárez PC
    Clinics (Sao Paulo); 2017 Aug; 72(8):499-509. PubMed ID: 28954010
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reevaluating the placebo effect in medical practice.
    Colloca L; Jonas WB; Killen J; Miller FG; Shurtleff D
    Z Psychol; 2014; 222(3):124-127. PubMed ID: 25360397
    [TBL] [Abstract][Full Text] [Related]  

  • 49. White patients' physical responses to healthcare treatments are influenced by provider race and gender.
    Howe LC; Hardebeck EJ; Eberhardt JL; Markus HR; Crum AJ
    Proc Natl Acad Sci U S A; 2022 Jul; 119(27):e2007717119. PubMed ID: 35749352
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Acupuncture for post-stroke depression: a systematic review and meta-analysis.
    Liu R; Zhang K; Tong QY; Cui GW; Ma W; Shen WD
    BMC Complement Med Ther; 2021 Apr; 21(1):109. PubMed ID: 33794857
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of open-label placebos in clinical trials: a systematic review and meta-analysis.
    von Wernsdorff M; Loef M; Tuschen-Caffier B; Schmidt S
    Sci Rep; 2021 Feb; 11(1):3855. PubMed ID: 33594150
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Systematic Review of Health Economic Impact Evaluations of Risk Prediction Models: Stop Developing, Start Evaluating.
    van Giessen A; Peters J; Wilcher B; Hyde C; Moons C; de Wit A; Koffijberg E
    Value Health; 2017 Apr; 20(4):718-726. PubMed ID: 28408017
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.
    Picot J; Jones J; Colquitt JL; Gospodarevskaya E; Loveman E; Baxter L; Clegg AJ
    Health Technol Assess; 2009 Sep; 13(41):1-190, 215-357, iii-iv. PubMed ID: 19726018
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Placebo Economics: A Systematic Review About the Economic Potential of Utilizing the Placebo Effect.
    Hamberger J; Meissner K; Hinterberger T; Loew T; Weimer K
    Front Psychiatry; 2019; 10():653. PubMed ID: 31572237
    [No Abstract]   [Full Text] [Related]  

  • 55. Barriers to generalizability of health economic evaluations in Latin America and the Caribbean region.
    Augustovski F; Iglesias C; Manca A; Drummond M; Rubinstein A; Martí SG
    Pharmacoeconomics; 2009; 27(11):919-29. PubMed ID: 19888792
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.
    Forbes C; Shirran L; Bagnall AM; Duffy S; ter Riet G
    Health Technol Assess; 2001; 5(28):1-110. PubMed ID: 11701100
    [TBL] [Abstract][Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.